Multicenter randomized controlled study of the influence of lactic peritoneal dialysis fluid on the peritoneum of peritoneal dialysis patients

Multicenter randomized controlled study of the influence of lactic peritoneal dialysis fluid on the peritoneum of peritoneal dialysis patients - RCT of the influence of lactic PD fluid on the peritoneum

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022551

Enrollment

Registered

2016-05-31

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRF on peritoneal dialysis

Interventions

Treatment for 26 months with decided PD fluid After treatment with lactic acid PD fluid for 2 months, patients are treated with lactic acid PD fluid or bicarbonate/ lactic acid PD fluid for 24 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Peritoneal dialysis patients Patients who are treated with lactic PD fluid(Dianeal N)

Exclusion criteria

Exclusion criteria: Patients with malignant tumor Patients with infection at the registration

Design outcomes

Primary

Measure	Time frame
The concentration of IL6 in peritoneal dialysis drainage(2,8,14,20,26 months after starting the study)	—

Countries

Japan

Contacts

Public ContactChieko Higuchi

Tokyo women's Medical University, Medical Center East Division of Blood Purification and Nephrology

Chiekogm@dnh.twmu.ac.jp03-3810-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026